KOPRAN Financial Statement Analysis
|
||
The Revenues of KOPRAN have decreased by -2.91% YoY .
The Earnings Per Share (EPS) of KOPRAN has decreased by -55.37 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
KOPRAN Last 5 Annual Financial Results
[BOM: 524280|NSE : KOPRAN]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹478 Cr | ₹492 Cr | ₹359 Cr | ₹358 Cr | ₹313 Cr |
Expenses | ₹390 Cr | ₹410 Cr | ₹313 Cr | ₹312 Cr | ₹284 Cr |
Operating Profit (Excl OI) | ₹87 Cr | ₹82 Cr | ₹47 Cr | ₹45 Cr | ₹29 Cr |
Other Income | ₹11 Cr | ₹18 Cr | ₹0.63 Cr | ₹3.96 Cr | ₹11 Cr |
Interest | ₹5.12 Cr | ₹6.24 Cr | ₹8.91 Cr | ₹8.99 Cr | ₹8.60 Cr |
Depreciation | ₹11 Cr | ₹10 Cr | ₹9.58 Cr | ₹8.74 Cr | ₹8.51 Cr |
Profit Before Tax | ₹82 Cr | ₹83 Cr | ₹28 Cr | ₹32 Cr | ₹23 Cr |
Profit After Tax | ₹61 Cr | ₹62 Cr | ₹21 Cr | ₹24 Cr | ₹20 Cr |
Consolidated Net Profit | ₹61 Cr | ₹62 Cr | ₹21 Cr | ₹24 Cr | ₹20 Cr |
Earnings Per Share (Rs) | ₹5.65 | ₹12.66 | ₹14.24 | ₹4.86 | ₹5.55 |
PAT Margin (%) | 4.88 | 12.60 | 12.29 | 5.81 | 6.71 |
ROE(%) | 6.29 | 18.19 | 28.34 | 11.74 | 15.34 |
ROCE(%) | 8.30 | 21.40 | 30.40 | 13.69 | 16.30 |
Total Debt/Equity(x) | 0.17 | 0.17 | 0.27 | 0.47 | 0.58 |
Key Financials |
||
Market Cap | : | ₹ 1,280.0 Cr |
Revenue (TTM) | : | ₹ 577.4 Cr |
Net Profit(TTM) | : | ₹ 40.4 Cr |
EPS (TTM) | : | ₹ 8.4 |
P/E (TTM) | : | 31.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
KOPRAN | 15.6% | -1.9% | 154.6% |
SUN PHARMACEUTICAL INDUSTRIES | -0.8% | 4% | 61.6% |
DIVIS LABORATORIES | -2.1% | -6% | 26.4% |
CIPLA | 1.5% | 3.3% | 70.6% |
DR REDDYS LABORATORIES | 0.7% | 0.4% | 44.6% |
TORRENT PHARMACEUTICALS | -4% | -2.8% | 70.3% |
ABBOTT INDIA | 6% | -3% | 39.7% |
ZYDUS LIFESCIENCES | 0.3% | 11.1% | 109.1% |
ALKEM LABORATORIES | -1.5% | -8.6% | 63.1% |
KOPRAN Revenues
[BOM: 524280|NSE : KOPRAN]
Y-o-Y | -2.91 % |
5 Yr CAGR | 11.11 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹478 Cr | -2.91 | |
Mar2022 | ₹492 Cr | 36.81 | |
Mar2021 | ₹359 Cr | 0.45 | |
Mar2020 | ₹358 Cr | 14.23 | |
Mar2019 | ₹313 Cr | - |
KOPRAN Operating Profit
[BOM: 524280|NSE : KOPRAN]
Y-o-Y | 6.89 % |
5 Yr CAGR | 31.64 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹87 Cr | 6.89 | |
Mar2022 | ₹82 Cr | 74.78 | |
Mar2021 | ₹47 Cr | 2.78 | |
Mar2020 | ₹45 Cr | 56.38 | |
Mar2019 | ₹29 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 10.13 % |
5 Yr CAGR | 18.49 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 18.27% | 10.13 | |
Mar2022 | 16.59% | 27.71 | |
Mar2021 | 12.99% | 2.36 | |
Mar2020 | 12.69% | 36.89 | |
Mar2019 | 9.27% | - |
KOPRAN Profit After Tax
[BOM: 524280|NSE : KOPRAN]
Y-o-Y | -0.93 % |
5 Yr CAGR | 31.38 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹61 Cr | -0.93 | |
Mar2022 | ₹62 Cr | 193.08 | |
Mar2021 | ₹21 Cr | -12.50 | |
Mar2020 | ₹24 Cr | 17.27 | |
Mar2019 | ₹20 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -61.27 % |
5 Yr CAGR | -7.65 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 4.88 % | -61.27 | |
Mar2022 | 12.6 % | 2.52 | |
Mar2021 | 12.29 % | 111.53 | |
Mar2020 | 5.81 % | -13.41 | |
Mar2019 | 6.71 % | - |
KOPRAN Earnings Per Share (EPS)
[BOM: 524280|NSE : KOPRAN]
Y-o-Y | -55.37 % |
5 Yr CAGR | 0.45 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹5.65 | -55.37 | |
Mar2022 | ₹13 | -11.10 | |
Mar2021 | ₹14 | 193.00 | |
Mar2020 | ₹4.86 | -12.43 | |
Mar2019 | ₹5.55 | - |
KOPRAN Return on Capital Employed (ROCE)
[BOM: 524280|NSE : KOPRAN]
Y-o-Y | -61.21 % |
5 Yr CAGR | -15.53 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 8.3% | -61.21 | |
Mar2022 | 21.4% | -29.61 | |
Mar2021 | 30.4% | 122.06 | |
Mar2020 | 13.69% | -16.01 | |
Mar2019 | 16.3% | - |
KOPRAN Share Price vs Sensex
Current Share Price | : | ₹265.6 |
Current MarketCap | : | ₹ 1,280.0 Cr |
Updated EOD on | : | Mar 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 15.6% |
-1.9% |
154.6% |
SENSEX | -1% |
1% |
24.9% |
KOPRAN related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | -2.1% | -2.4% | 59.2% |
S&P BSE ALLCAP | -2.3% | -1.4% | 38% |
S&P BSE MIDSMALLCAP | -3.9% | -5.5% | 55.7% |
S&P BSE SMALL CAP | -4.1% | -7.4% | 53.4% |
You may also like the below Video Courses
FAQ about KOPRAN Financials
How the annual revenues of KOPRAN have changed ?
The Revenues of KOPRAN have decreased by -2.91% YoY .
How the Earnings per Share (EPS) of KOPRAN have changed?
The Earnings Per Share (EPS) of KOPRAN has decreased by -55.37 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
DR REDDYS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD vs